Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
1.94
0.06 (3.19%)
At close: Aug 15, 2025, 3:07 PM

Humacyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-148.7M -110.78M -11.96M -26.48M
Depreciation & Amortization
7.19M 7.72M 8.21M 8.24M
Stock-Based Compensation
6.14M 6.83M 6.18M 10.15M
Other Working Capital
2.27M 1.73M 1.39M -116K
Other Non-Cash Items
36.94M 16.35M -74.41M -54.74M
Deferred Income Tax
n/a n/a -173K -17.8M
Change in Working Capital
311K 6.57M 1.03M -557K
Operating Cash Flow
-98.12M -73.31M -71.13M -81.19M
Capital Expenditures
-1.57M -2.28M -1.05M -220K
Cash Acquisitions
n/a n/a -5.89M n/a
Purchase of Investments
n/a n/a -10.11M -8M
Sales Maturities Of Investments
n/a 2.11M 16M n/a
Other Investing Acitivies
n/a n/a 5.89M n/a
Investing Cash Flow
-1.57M -173K 4.84M -8.22M
Debt Repayment
-2.58M -34.07M -1.98M 27.93M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
27.71M 38.01M n/a 238.46M
Financial Cash Flow
114.18M 4.51M -1.45M 266.98M
Net Cash Flow
14.49M -68.97M -67.73M 177.57M
Free Cash Flow
-99.69M -75.58M -72.18M -81.41M